Home / Dopamine / United States
US ATC C01CA04 · updated 2 Nov 2026
Dopamine shortage in United States
Is there a Dopamine shortage in United States?
Yes. As of 2 Nov 2026, 11 Dopamine products are reported short in United States, the first since 6 Nov 2017. No return date has been given. Main reason: not stated.
Also short in Spain. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) | Baxter Healthcare | 6 Nov 2017 | not given | Not stated |
| US | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) | Baxter Healthcare | 6 Nov 2017 | not given | Not stated |
| US | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) | Baxter Healthcare | 6 Nov 2017 | not given | Not stated |
| US | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) | Baxter Healthcare | 6 Nov 2017 | not given | Not stated |
| US | Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Not stated |
| US | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) | Hikma Pharmaceuticals USA, Inc. | 6 Nov 2017 | not given | Increased demand Demand increase for the drug |
| US | Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) | Hikma Pharmaceuticals USA, Inc. | 6 Nov 2017 | not given | Increased demand Demand increase for the drug |
| US | Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) limited | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Other |
| US | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Not stated |
| US | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Not stated |
| US | Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) | Hospira, Inc., a Pfizer Company | 6 Nov 2017 | not given | Other |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).